within Pharmacolibrary.Drugs.ATC.L;

model L02BG06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.42,
    Cl             = 0.4116666666666667,
    adminDuration  = 600,
    adminMass      = 0.025,
    adminCount     = 1,
    Vd             = 0.048,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006516666666666667,
    Tlag           = 15.0
  );

  annotation(Documentation(
    info ="<html><body><p>Exemestane is a steroidal aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer, primarily in postmenopausal women. It reduces the production of estrogen and is approved for use as adjuvant or advanced treatment for breast cancer.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters as observed in healthy postmenopausal females after oral administration of a single 25 mg exemestane dose.</p><h4>References</h4><ol><li><p>Scott, LJ, &amp; Wiseman, LR (1999). Exemestane. <i>Drugs</i> 58(4) 675–682. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199958040-00007&quot;>10.2165/00003495-199958040-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10551437/&quot;>https://pubmed.ncbi.nlm.nih.gov/10551437</a></p></li><li><p>Rizwanullah, M, et al., &amp; Amin, S (2023). Polymer-lipid hybrid nanoparticles of exemestane for improved oral bioavailability and anti-tumor efficacy: An extensive preclinical investigation. <i>International journal of pharmaceutics</i> 642 123136–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ijpharm.2023.123136&quot;>10.1016/j.ijpharm.2023.123136</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37311498/&quot;>https://pubmed.ncbi.nlm.nih.gov/37311498</a></p></li><li><p>Elzoghby, AO, et al., &amp; Elgindy, NA (2017). Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy. <i>Nanomedicine (London, England)</i> 12(24) 2785–2805. DOI:<a href=&quot;https://doi.org/10.2217/nnm-2017-0247&quot;>10.2217/nnm-2017-0247</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29094642/&quot;>https://pubmed.ncbi.nlm.nih.gov/29094642</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L02BG06;
